Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dydrogesterone for Endometrial Polyps
NCT03790215Phase 4Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Feb 2019
- Primary completion
- Sep 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dydrogesterone in Endometrial polyps, sponsored by Peking Union Medical College Hospital. Primary endpoints: Regression rate of endometrial polyps at 3 months and Relapse rate of endometrial polyps at 6 months. Started Feb 2019; status: completed.
02
Drugs
dydrogesterone
03
Conditions
Endometrial polyps
Beyond the preview
Go deeper on NCT03790215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03790215.